Compare ARK Genomic Revolution ETF (ARKG) vs Blackrock Inc (BLK) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Blackrock Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Blackrock Inc trades at $1,034.01 (market cap $160.59B). The key difference: Blackrock Inc pays a 2.21% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | BLK | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $1.20K |
52-Week Low | $23.09 | $922.90 |
Market Cap | — | $160.59B |
Volume | — | 641,547 |
Enterprise Value | — | $162.41B |
Dividend Yield | — | 2.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
BlackRock (BLK) trades at $1,036.11, up 1.61% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows bearish technical signals but maintains solid fundamentals with $24.22B revenue and 24.4% net margin. Recent developments include the launch of a new Nasdaq-100 ETF challenging Invesco QQQ, with Q2 2026 earnings expected on July 15.
Outlook remains positive with 76% analyst buy ratings and $1,270 consensus price target representing 22.6% upside. Key risks include market volatility affecting asset management fees and competitive pressure in ETF space. The company's pivot to private markets and AI-driven growth initiatives provide long-term opportunities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Blackrock Inc
BlackRock, Inc. provides investment management services to institutional clients and to retail investors through various investment vehicles. The Company manages funds, as well as offers risk management services. BlackRock serves governments, companies, and foundations worldwide.
Read more on BLK →
